25-Hydroxyvitamin D and Risk of Stroke: Possible Mediation by Statin Therapy? | Zendy

ChiHo Lee | Zendy; Jerry R. Greenfield | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

25-Hydroxyvitamin D and Risk of Stroke: Possible Mediation by Statin Therapy?

Author(s) -

ChiHo Lee,

Jerry R. Greenfield

Publication year - 2008

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.108.537167

Subject(s) - medicine , statin , diabetes mellitus , confounding , mediation , stroke (engine) , residual risk , body mass index , endocrinology , mechanical engineering , engineering , political science , law

To the Editor:We read with interest a recent study by Pilz et al, which reported an association between low levels of 25-hydroxyvitamin D (25-OH D) and an increased risk of fatal stroke.1 In their study, low circulating 25-OH D levels predicted fatal stroke, independent of traditional cerebrovascular risk factors, including age, sex, body mass index, lipid levels, smoking, hypertension and diabetes mellitus. Despite adjustment for low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels, the …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research